These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9379315)

  • 1. Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro.
    Tani-Ishii N; Tsunoda A; Umemoto T
    J Periodontal Res; 1997 Aug; 32(6):480-6. PubMed ID: 9379315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha.
    Tani-Ishii N; Tsunoda A; Teranaka T; Umemoto T
    J Dent Res; 1999 Oct; 78(10):1617-23. PubMed ID: 10520966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human osteoclast and giant cell differentiation: the apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the in situ expression of osteopontin mRNA.
    Connor JR; Dodds RA; James IE; Gowen M
    J Histochem Cytochem; 1995 Dec; 43(12):1193-201. PubMed ID: 8537635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone.
    Dodds RA; Connor JR; James IE; Rykaczewski EL; Appelbaum E; Dul E; Gowen M
    J Bone Miner Res; 1995 Nov; 10(11):1666-80. PubMed ID: 8592943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclasts resorb protein-free mineral (Osteologic discs) efficiently in the absence of osteopontin.
    Contractor T; Babiarz B; Kowalski AJ; Rittling SR; Sørensen ES; Denhardt DT
    In Vivo; 2005; 19(2):335-41. PubMed ID: 15796195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion.
    Razzouk S; Brunn JC; Qin C; Tye CE; Goldberg HA; Butler WT
    Bone; 2002 Jan; 30(1):40-7. PubMed ID: 11792563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
    Lee SK; Goldring SR; Lorenzo JA
    Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro.
    Okazaki R; Toriumi M; Fukumoto S; Miyamoto M; Fujita T; Tanaka K; Takeuchi Y
    Endocrinology; 1999 Nov; 140(11):5060-5. PubMed ID: 10537132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of bone sialoprotein and osteopontin mRNA expression by dexamethasone and 1,25-dihydroxyvitamin D3 in rat bone organ cultures.
    Chen J; Thomas HF; Sodek J
    Connect Tissue Res; 1996; 34(1):41-51. PubMed ID: 8835847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin mRNA expression during bone resorption: an in situ hybridization study of induced ectopic bone in the rat.
    Arai N; Ohya K; Ogura H
    Bone Miner; 1993 Aug; 22(2):129-45. PubMed ID: 8251765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of bone sialoprotein mRNA during bone formation and resorption induced by colchicine in rat tibial bone marrow cavity.
    Arai N; Ohya K; Kasugai S; Shimokawa H; Ohida S; Ogura H; Amagasa T
    J Bone Miner Res; 1995 Aug; 10(8):1209-17. PubMed ID: 8585425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin K mRNA detection is restricted to osteoclasts during fetal mouse development.
    Dodds RA; Connor JR; Drake F; Feild J; Gowen M
    J Bone Miner Res; 1998 Apr; 13(4):673-82. PubMed ID: 9556067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells.
    Wei P; Jiao L; Qin LP; Yan F; Han T; Zhang QY
    Zhong Xi Yi Jie He Xue Bao; 2009 Apr; 7(4):342-8. PubMed ID: 19361364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin is required for mechanical stress-dependent signals to bone marrow cells.
    Ishijima M; Tsuji K; Rittling SR; Yamashita T; Kurosawa H; Denhardt DT; Nifuji A; Ezura Y; Noda M
    J Endocrinol; 2007 May; 193(2):235-43. PubMed ID: 17470514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy.
    Yamate T; Mocharla H; Taguchi Y; Igietseme JU; Manolagas SC; Abe E
    Endocrinology; 1997 Jul; 138(7):3047-55. PubMed ID: 9202251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel culture system to generate osteoclasts and bone resorption using porcine bone marrow cells: role of M-CSF.
    Scheven BA; Milne JS; Robins SP
    Biochem Biophys Res Commun; 1997 Feb; 231(1):231-5. PubMed ID: 9070255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
    Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
    Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vascular endothelial growth factor-C and -D on osteoclast differentiation and function in human peripheral blood mononuclear cells.
    Motokawa M; Tsuka N; Kaku M; Kawata T; Fujita T; Ohtani J; Matsuda Y; Terao A; Tanne K
    Arch Oral Biol; 2013 Jan; 58(1):35-41. PubMed ID: 22771550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.